Silexion Therapeutics Corp (NASDAQ:SLXN)’s traded shares stood at 7.45 million during the last session, with the company’s beta value hitting 0.02. At the close of
Silexion Therapeutics Corp (NASDAQ:SLXN)’s traded shares stood at 3.95 million during the latest session, with the company’s beta value hitting 0.02. At the last check
In the latest trading session, 6.74 million Silexion Therapeutics Corp (NASDAQ:SLXN) shares changed hands as the company’s beta touched 0.02. With the company’s most recent
In the last trading session, 0.17 million shares of the Silexion Therapeutics Corp (NASDAQ:SLXN) were traded, and its beta was -0.02. Most recently the company’s
In today’s recent session, 6.56 million shares of the Silexion Therapeutics Corp (NASDAQ:SLXN) have been traded, and its beta is -0.06. Most recently the company’s
Silexion Therapeutics Corp (NASDAQ:SLXN)’s traded shares stood at 3.9 million during the last session, with the company’s beta value hitting -0.06. At the close of
Silexion Therapeutics Corp (NASDAQ:SLXN)’s traded shares stood at 3.54 million during the latest session, with the company’s beta value hitting -0.06. At the last check
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
